Notices

Tender for Supply of Smoke Chamber consist Of One Air Chamber, One Smoke Chamber And One Animal Chamber New

Supply of Rotary Evaporator with Chiller and Vacume Pump New

Extension of Rate Contract 2019-20 for 3 months New

Annual Job Contract for up keeping Horticulture & allied work New

PO Order regarding items End repair/Da tailing module (L) 1, Quick ligation module(S) 1... New

Tender for Supply of Orbital Shaker as per tender document New

Tender for High Pressure Liquid Chromatography New

Supply of Nanodrop/Nanovolume Spectrophotometer with Cuvette applications New

Supply of sonicater as per specification in the tender document New

Supply of biomolecule imager as per technical specification Attached New

Cancellation of Tender New

Cancellation of Tender New

Supply of High Pressure Liquid Chromatography New

Empanelment of Service Provider/s for cGMP manufacture of Investigational New Drugs and their Formulations for Clinical Trials New

Supply of Peristaltic Pump New

Corrigendum regarding Date Extension and Bidder Inclusion for tender of Multimode Microplate Reader New

Tender for Rotary Evaporator Bundled With The Vaccump pump and recirculating chiller New

Corrigendum regarding Date Extension and Clarification for cGMP manufacture of investigational new drugs and their formulation for clinical trials/services New

Tender for Supply of GC-FID-MS System New

Supply of UPLC Syatem New

Geneal Terms & Conditions for Tender

GST Certificate

Please Visit Central Public Procurement Portal (CPP Portal.) for CDRI Tenders


Message from Director


Prof. Tapas K. Kundu

Director, CSIR-CDRI

Welcome to the new website of CSIR-Central Drug Research Institute (CSIR-CDRI), a premier institute which has achieved seamless integration of basic and translational research, and evolved as aunique state run comprehensive centre for drug research and development in Asian continent. Sixty-acre new campus, comprising of laboratory complex and R&D support facilities, provide a vibrant atmosphere for multidisciplinary R&D and human resource development. Read More...


Research Area

CDRI
CSIR-CDRI

Development of new drugs/drug combinations as therapeutic interventions for malaria, leishmaniasis and filariasis

Development of new drugs/drug combinations as therapeutic intervention for malaria, leishmanial and filariasis


Identification of unique targets and pathways for future interventions


Investigations on parasite biology and host-parasite interactions.

CDRI
CSIR-CDRI

Development of novel agents for fracture healing and management of osteoporosis through modern drug design..

Development of novel agents for fracture healing and management of osteoporosis through modern drug design, scientific validation of traditional remedies and generation of new knowledge

cdri
CSIR-CDRI

Development of novel agents for fracture healing and management of osteoporosis through modern drug design..

Development of novel agents for fracture healing and management of osteoporosis through modern drug design, scientific validation of traditional remedies and generation of new knowledge

CDRI
cdri

The World Health Organization has defined Antimicrobial resistance as the ability of a microorganism to stop an antimicrobial from working against it..

The World Health Organization(WHO) has defined Antimicrobial resistance (AMR) as the ability of a microorganism to stop an antimicrobial from working against it. As a result, standard treatments become ineffective, infections persist and may spread to others. It has further stated “AMR is of particular concern in developing nations, including India, where the burden of infectious disease is high and healthcare spending is low. The country has among the highest bacterial disease burden in the world. Antibiotics, therefore, have a critical role in limiting morbidity and mortality in the country.

CDRI
CSIR-CDRI

Affordable drugs for lifestyle diseases (CVS,CNS and related disorders) to achieve the dream “SWASTH BHARAT”

As per the estimates in the WHO non communicable disease (NCD) Country Profile 2014, Cardio- vascular disease (CVD) is the leading cause of Deaths in India and accounts for 26% of all deaths. As per WHO more than 4% of Indian population (3rd in world after USA and China) is obese, which is the main reason of major CVDs. In 2008, WHO declared dementia/AD as a priority condition through the Mental Health Gap Action Programs


cdri
CSIR-CDRI

Development of novel therapeutic agents for CVS, CNS and related disorders, cancer, fertility regulation (male/female)..

Development of novel therapeutic agents for CVS, CNS and related disorders, cancer, fertility regulation (male/female) and management of endocrine disorders through modern drug design, scientific validation of traditional remedies

CDRI
cdri

Development of novel therapeutic agents for CVS, CNS and related disorders, cancer, fertility regulation (male/female)..

Development of novel therapeutic agents for CVS, CNS and related disorders, cancer, fertility regulation (male/female) and management of endocrine disorders through modern drug design, scientific validation of traditional remedies

CDRI
CSIR-CDRI

Discovery and Development of New Avenues for Cancer Therapy and Diagnosis Making Cancer Care Affordable in India

Discovery and Development of New Avenues for Cancer Therapy and Diagnosis Making Cancer Care Affordable in India

cdri
cdri

Pre-clinical and clinical development of drug substances and drug products for diseases of national importance..

Pre-clinical and clinical development of drug substances and drug products for diseases of national importance, international relevance and public health needs


Continued engagement with drug regulation and pharmaceutical policy making in India as well as internationally

Our Drugs

E-MAL Arteether

For cerebral malaria as a second line treatment for chloroquine resistant cases, licensed to Themis Chemicals Ltd., Mumbai in 1997.

Keen Mind Bacopa Extract

Keenmind is marketed through Soho Flordis International, Sydney, Australia and is available now in India.

Saheli Centchroman

First non steroidal female oral contraceptive Licensed to HLL Lifecare Ltd., in 1992 & being marketed as SAHELI.

Reunion Dalzbone

Success Story of Development of New Herbal Medication for Bone Health.


MoUs/Licenses

Facilities & Services

Events & Activities


Campus Life@ CDRI



Important Links

Style Switcher